Most consumers are familiar with the idea of probiotics — particularly when it comes to gastrointestinal health. But could they actually benefit HIV and AIDS patients?
That’s a question being examined in a medical probiotic product created by Gaithersburg startup ExeGi Pharma LLC. That product, Visbiome, is planned for launch this fall and was originally designed to help the treatment of patients with ailments such as ulcerative colitis or irritable bowel syndrome.
{iframe}http://www.bizjournals.com/washington/blog/2015/08/can-a-gaithersburg-companys-probiotic-help-hiv.html?ana=e_du_pap&s=article_du&ed=2015-08-19&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1440172231{/iframe}